JOHNSON B KRISTINE

Director · CLPT, ATRC, FNA

As of 2026-09-16, JOHNSON B KRISTINE has 10 Form 4 transactions on record across 3 companies — 2 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $3.4MIndirect: $0$3.4Mas of 2026-09-16
  • Direct $3.4M
  • Indirect $0
ATRCdirect55,954 sh$3.2M
CLPTdirect12,820 sh$172K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

CLPT · 6 trades
2026-05-21: Award / grant, 12,820 sh ($0)2025-05-22: Award / grant, 12,417 sh ($0)2025-05-16: Option exercise, 21,093 sh2025-05-16: Option exercise, 21,093 sh2025-05-16: Option exercise, 21,093 sh2025-05-16: Option exercise, 21,093 sh
ATRC · 2 trades
2026-05-18: Award / grant, 6,144 sh ($0)2025-05-19: Award / grant, 5,401 sh ($0)
FNA · 2 trades
2025-04-21: Disposition, 47,347 sh2025-04-21: Disposition, 47,347 sh

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
10 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-05-21CLPTAward / grant12,82012,820Form 4
2026-05-18ATRCAward / grant6,14455,954Form 4
2025-05-22CLPTAward / grant12,41712,417Form 4
2025-05-19ATRCAward / grant5,40149,810Form 4
2025-05-16CLPTOption exercise21,0930Form 4
2025-05-16CLPTOption exercise21,09358,699Form 4
2025-05-16CLPTOption exercise21,0930Form 4
2025-05-16CLPTOption exercise21,09358,699Form 4
2025-04-21FNADisposition47,3470Form 4
2025-04-21FNADisposition47,3470Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.